|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$88,881.03 |
2.80% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$87,174.92 |
2.75% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$85,972.23 |
2.71% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$85,554.54 |
2.70% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$85,200.84 |
2.69% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$81,469.21 |
2.57% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$80,955.90 |
2.55% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$79,670.02 |
2.51% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$77,853.13 |
2.45% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$77,391.18 |
2.44% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$77,414.40 |
2.44% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$77,004.80 |
2.43% |
| Waters Corporation |
WAT |
941848103 |
184 |
$75,325.92 |
2.37% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$73,936.75 |
2.33% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$72,426.04 |
2.28% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$71,075.01 |
2.24% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$70,570.68 |
2.22% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$69,419.01 |
2.19% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$69,026.04 |
2.18% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$68,903.28 |
2.17% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$68,054.30 |
2.14% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$65,202.28 |
2.05% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$64,374.60 |
2.03% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$64,034.20 |
2.02% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$63,698.04 |
2.01% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$63,658.92 |
2.01% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$62,078.31 |
1.96% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$61,966.81 |
1.95% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$60,536.70 |
1.91% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$60,335.20 |
1.90% |
| Steris Plc |
STE |
G8473T100 |
265 |
$59,516.35 |
1.88% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$58,914.30 |
1.86% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$57,620.52 |
1.82% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$57,346.26 |
1.81% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$55,570.02 |
1.75% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$53,935.90 |
1.70% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$53,811.96 |
1.70% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$53,493.21 |
1.69% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$52,744.62 |
1.66% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$51,045.08 |
1.61% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$50,572.85 |
1.59% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$49,790.40 |
1.57% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$48,120.78 |
1.52% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$47,671.00 |
1.50% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$45,649.00 |
1.44% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$45,421.82 |
1.43% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,567.87 |
1.40% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$44,244.00 |
1.39% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$41,464.38 |
1.31% |
| US Dollar |
$USD |
|
12,746 |
$12,746.04 |
0.40% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
| Hong Kong Dollar |
$HKD |
|
-1,896 |
($241.84) |
-0.01% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|